Evidence map›Paper›PMID 36433631›Full record

ArticleThe international journal of biostatistics2024

Highly robust causal semiparametric U-statistic with applications in biomedical studies.

Anqi Yin, Ao Yuan, Ming T Tan

Abstract read
In one paragraph

Article in The international journal of biostatistics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Anqi YinDepartment of Biostatistics, Bioinformatics and Biomathematics Georgetown University, Washington, DC 20057, USA.ORCID https://orcid.org/0000-0001-6572-1931
Ao YuanDepartment of Biostatistics, Bioinformatics and Biomathematics Georgetown University, Washington, DC 20057, USA.
Ming T TanDepartment of Biostatistics, Bioinformatics and Biomathematics Georgetown University, Washington, DC 20057, USA.

Funding

Robust Causal Comparisons of Nonrandomized Oncology StudiesR21CA270585 · NCI · GEORGETOWN UNIVERSITY · PI TAN, MING TONY · 2022 to 2023
$392k
NCI NIH HHS R21 CA270585
6 · The paper itself

Abstract

With our increased ability to capture large data, causal inference has received renewed attention and is playing an ever-important role in biomedicine and economics. However, one major methodological hurdle is that existing methods rely on many unverifiable model assumptions. Thus robust modeling is a critically important approach complementary to sensitivity analysis, where it compares results under various model assumptions. The more robust a method is with respect to model assumptions, the more worthy it is. The doubly robust estimator (DRE) is a significant advance in this direction. However, in practice, many outcome measures are functionals of multiple distributions, and so are the associated estimands, which can only be estimated via U-statistics. Thus most existing DREs do not apply. This article proposes a broad class of highly robust U-statistic estimators (HREs), which use semiparametric specifications for both the propensity score and outcome models in constructing the U-statistic. Thus, the HRE is more robust than the existing DREs. We derive comprehensive asymptotic properties of the proposed estimators and perform extensive simulation studies to evaluate their finite sample performance and compare them with the corresponding parametric U-statistics and the naive estimators, which show significant advantages. Then we apply the method to analyze a clinical trial from the AIDS Clinical Trials Group.

Indexed as

causal effecthighly robust estimationsemiparametric modelU-statistic

Identifiers

PMID36433631
PMCPMC10225018

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.